Skip to main content
Erschienen in: Rheumatology International 4/2008

01.02.2008 | Case Report

Dramatic progression of skin involvement in systemic sclerosis after the appearance of anti-Scl70 antibody: a case report

verfasst von: Paola Caramaschi, Alessandro Volpe, Antonio Carletto, Lisa Maria Bambara, Domenico Biasi

Erschienen in: Rheumatology International | Ausgabe 4/2008

Einloggen, um Zugang zu erhalten

Abstract

The authors describe a young man suffering from systemic sclerosis who showed a dramatic progression of skin involvement after the appearance of anti-Scl70 antibody.
Literatur
1.
Zurück zum Zitat Derk CT, Jimenez SA (2003) Systemic sclerosis: current view of its pathogenesis. Autoimmun Rev 2:181–191PubMedCrossRef Derk CT, Jimenez SA (2003) Systemic sclerosis: current view of its pathogenesis. Autoimmun Rev 2:181–191PubMedCrossRef
2.
Zurück zum Zitat Walker UA, Tyndall A, Czirjak L, Denton C., Farge-Bancel D, Kowal-Bielecka O, Muller-Ladner U, Bocelli-Tyndall C, Matucci-Cerinic M and EUSTAR Co-authors (2007) Clinical risk assessment of organ manifestations in systemic sclerosis—a report from the EULAR Scleroderma Trials and Research (EUSTAR) group data base. Ann Rheum Dis 66:754–763 Walker UA, Tyndall A, Czirjak L, Denton C., Farge-Bancel D, Kowal-Bielecka O, Muller-Ladner U, Bocelli-Tyndall C, Matucci-Cerinic M and EUSTAR Co-authors (2007) Clinical risk assessment of organ manifestations in systemic sclerosis—a report from the EULAR Scleroderma Trials and Research (EUSTAR) group data base. Ann Rheum Dis 66:754–763
3.
Zurück zum Zitat Jacobsen S, Ullman S, Shen GQ, Wiik A, Haberq P (2001) Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis. J Rheumatol 28:2454–2459PubMed Jacobsen S, Ullman S, Shen GQ, Wiik A, Haberq P (2001) Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis. J Rheumatol 28:2454–2459PubMed
4.
Zurück zum Zitat Diot E, Giraudeau B, Diot P, Degenee D, Ritz L, Guilmot JL, Lemarie E (1999) Is anti-topoisomerase I a serum marker of pulmonary involvement in systemic sclerosis? Chest 116:715–720PubMedCrossRef Diot E, Giraudeau B, Diot P, Degenee D, Ritz L, Guilmot JL, Lemarie E (1999) Is anti-topoisomerase I a serum marker of pulmonary involvement in systemic sclerosis? Chest 116:715–720PubMedCrossRef
5.
Zurück zum Zitat Steen VD (2005) Autoantibodies in systemic sclerosis. Seminars Arthritis Rheum 35:35–42CrossRef Steen VD (2005) Autoantibodies in systemic sclerosis. Seminars Arthritis Rheum 35:35–42CrossRef
6.
Zurück zum Zitat Cutolo M, Pizzorni C, Tuccio M, Burroni A, Craviotto C, Basso M, Seriolo B, Sulli A (2004) Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology 43:719–726PubMedCrossRef Cutolo M, Pizzorni C, Tuccio M, Burroni A, Craviotto C, Basso M, Seriolo B, Sulli A (2004) Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology 43:719–726PubMedCrossRef
7.
Zurück zum Zitat Hu PQ, Fertig N, Medsger TA Jr, Wright TM (2003) Correlation of serum anti-DNA topoisomerase I antibody levels with disease severity and activity in systemic sclerosis. Arthritis Rheum 48:1363–1373PubMedCrossRef Hu PQ, Fertig N, Medsger TA Jr, Wright TM (2003) Correlation of serum anti-DNA topoisomerase I antibody levels with disease severity and activity in systemic sclerosis. Arthritis Rheum 48:1363–1373PubMedCrossRef
8.
Zurück zum Zitat Hénault J, Tremblay M, Clément I, Raymond Y, Senécal Y (2004) DNA binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis. Arthritis Rheum 50:3265–3274PubMedCrossRef Hénault J, Tremblay M, Clément I, Raymond Y, Senécal Y (2004) DNA binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis. Arthritis Rheum 50:3265–3274PubMedCrossRef
9.
Zurück zum Zitat Hénault J, Robtaille G, Senécal Y (2006) DNA topoisomerase I binding to fibroblasts induces monocyte adhesion and activation in the presence of anti-topoisomerase I antibodies from systemic sclerosis patients. Arthritis Rheum 54:963–973PubMedCrossRef Hénault J, Robtaille G, Senécal Y (2006) DNA topoisomerase I binding to fibroblasts induces monocyte adhesion and activation in the presence of anti-topoisomerase I antibodies from systemic sclerosis patients. Arthritis Rheum 54:963–973PubMedCrossRef
Metadaten
Titel
Dramatic progression of skin involvement in systemic sclerosis after the appearance of anti-Scl70 antibody: a case report
verfasst von
Paola Caramaschi
Alessandro Volpe
Antonio Carletto
Lisa Maria Bambara
Domenico Biasi
Publikationsdatum
01.02.2008
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 4/2008
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-007-0434-2

Weitere Artikel der Ausgabe 4/2008

Rheumatology International 4/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.